NVDA's $5.5 billion H20 charge lands before Q1 earnings

NVIDIA just told investors its first quarter will carry up to $5.5 billion in charges. The source is the H20 product line: inventory write-downs, purchase commitment reserves, and related costs triggered by export control restrictions. The 8-K landed April 15, 2025, covering a report date of April 9.

That number is not a rounding error. NVIDIA's most recently filed revenue was $81.61 billion for the period ending April 26, 2026. A $5.5 billion single-quarter charge against that revenue base is meaningful, and it arrives as a pre-announcement rather than a footnote buried in a 10-Q. The company chose to surface it early through an Item 8.01 other events filing, which signals management wanted the number in the market before the full quarterly release.

The H20 Charge Is a Policy Event, Not a Demand Signal

The H20 is NVIDIA's chip designed to comply with earlier U.S. export restrictions on advanced AI accelerators sold into China. The charge tells investors that the regulatory perimeter moved again, making existing H20 inventory and committed supply no longer commercially viable at the scale NVIDIA had planned. This is a policy-driven impairment, not evidence that data-center demand for AI compute has softened. The distinction matters for how investors read the Q1 income statement.

The charge will suppress Q1 reported earnings. How much depends on whether the final figure lands at the full $5.5 billion or below it. The 8-K language says "up to approximately $5.5 billion," which leaves a range. The Q1 earnings release and the subsequent 10-Q will close that range and show how the charges were allocated across inventory write-downs versus purchase commitment reserves.

Filing Risk at the Ceiling

$NVDA's Filing Risk Score sits at 100, the highest reading on the scale. That ceiling reflects the density and severity of recent disclosure activity, and the H20 pre-announcement is the clearest driver. A score at this level means the filing tape requires active attention, not that the company is in financial distress. The elevated disclosure cadence here is a function of operating at the center of a fast-moving regulatory environment, where material events require rapid public disclosure.

The risk-factor diff between the February 2026 10-K and the February 2025 10-K shows 8 added candidates, 8 removed, and 3 materially changed Item 1A entries. That level of risk-factor churn over a single annual filing cycle reinforces the picture of a company whose disclosure obligations are actively evolving alongside its regulatory and competitive exposure.

What the Q1 Filing Needs to Resolve

The 8-K creates two open questions that the Q1 10-Q must answer. First, the exact charge split: how much is inventory write-down versus purchase commitment reserve matters for cash flow modeling, because purchase commitment charges can signal future cash outflows while inventory write-downs are largely non-cash. Second, whether NVIDIA updated its forward guidance to reflect any ongoing H20 revenue shortfall beyond the one-time charge.

The 8-K itself carries the standard forward-looking statement disclaimer and does not provide updated full-year guidance. Investors waiting for a revised revenue outlook will need the earnings call or the 10-Q.

On price, $NVDA has gained roughly 10.6% over the past 30 days and approximately 18.9% over the past 90 days as of May 20, 2026, with the stock sitting above its 20-day, 50-day, and 200-day moving averages. The stock hit a 52-week high on May 14, 2026. The market has largely looked through the H20 charge in the months since the April filing, pricing the data-center demand story rather than the export-control impairment. Whether that read holds depends on whether the Q1 10-Q reveals any secondary effects on forward bookings or customer mix.

The Q1 10-Q is the next document that changes the read. Specifically: the final charge amount, the cash versus non-cash split, any revision to the H20 product roadmap, and whether new risk language addresses the durability of the China revenue base under the current export control regime.

Research only. Not investment advice.